View Clinical Trial (Medical Research Study)
Impact of Exenatide on Sleep Duration and Quality in Type 2 Diabetes
| City: |
|
Chicago |
| State: |
|
Illinois |
| Zip Code: |
|
60637 |
| Conditions: |
|
Type 2 Diabetes |
| Purpose: |
|
This study investigates the effect of exenatide, a FDA approved medication for the
treatment of type 2 diabetes on sleep duration and quality. Individuals with type 2
diabetes will be studied before and during treatment with Exenatide.
Enrolled individuals will be asked to come to the University of Chicago for 3-4 outpatient
visits over the course of 3-4 months.
|
| Study Summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
Patients taking diabetes medications other then insulin will be included, but changes to
their medications may be made as deemed necessary by their physician. Patients on stable
medications for chronic and co-morbid conditions (high blood pressure, high cholesterol,
etc) will be eligible
Exclusion Criteria:
Patients with moderate or severe kidney disease and history of pancreatitis or patients on
insulin will be excluded, as Exenatide use is contraindicated or risky in these
conditions.
Patients with unstable cardiac, neurological or psychiatric disease and women who are
pregnant or trying to get pregnant will be excluded. Patients who have severe COPD,
severe neuropathy or chronic pain, which could impair sleep, will be excluded. Shift
workers will be also excluded.
|
| NCT ID: |
|
NCT01416649 |
| Primary Contact: |
|
Principal Investigator
Silvana Pannain, MD
University of Chicago
Annette Miller, MSN
Phone: 773-834-8871
Email: amiller@medicine.bsd.uchicago.edu
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
Chicago, Illinois 60637
United States
Annette Miller, MSN
Phone: 773-834-8871
Email: amiller@medicine.bsd.uchicago.edu
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 23, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|